| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |